RecruitingNot ApplicableNCT07037563

Developing an AI Pharmacy Chatbot for the Population of Hong Kong

Sponsor

The University of Hong Kong

Enrollment

280 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Artificial Intelligence (AI)Hypertension Hyperglycaemia Hyperlipidaemia

Summary

The primary objective of this study is to is to develop a conversational AI service (chatbot) in Hong Kong to assist patients and caregivers with inquires related to Hospital Authority (HA)-prescribed medications, and to evaluate its effectiveness in answering medication-related questions. The main questions it aims to answer are: 1. How satisfied are the patients and caregivers with this pharmacy chatbot? 2. How will the pharmacy chatbot impact eligible patients or caregivers on their (or the patient they are caring for) medication adherence, knowledge, and the consultation time with HA pharmacists? There will be an intervention group and a control group: 1. The intervention group will be invited to use the AI Pharmacy Chatbot online for 7 days through WhatsApp, a commonly used social media platform in Hong Kong. They can inquire about their medications prescribed under HA and get instant, validated answers from the chatbot. 2. The control group will not use the chatbot during the intervention period. To evaluate the chatbot's usability, researchers will measure patient satisfaction through usability questionnaires issued to the intervention group after their intervention period. Differences in medication adherence, medication knowledge, and HA pharmacist consultation time will also be measured between the intervention and control groups after the intervention period, to determine the chatbot's impact.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study develops and tests an AI-powered pharmacy chatbot designed to help patients in Hong Kong manage their medications for high blood sugar, high blood pressure, or high cholesterol. **You may be eligible if...** - You are 18 years old or older - You have been diagnosed with high blood sugar (hyperglycaemia), high blood pressure (hypertension), or high cholesterol (hyperlipidaemia) - You are currently taking prescribed medications from a Hong Kong Hospital Authority - You are a caregiver for someone who meets the above criteria **You may NOT be eligible if...** - You do not have access to a smartphone or the internet - You are unable to use a digital chatbot interface - You do not speak one of the supported languages Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAn AI pharmacy chatbot offering information related to HA-prescribed medication for hyperglycaemia, hypertension, and hyperlipidaemia

It is a chatbot for HA-prescribed medication used for treating hyperglycaemia, hypertension, and hyperlipidaemia, available through WhatsApp. All the responses will be extracted from a database, in which the content was obtained from and validated by pharmacists from the Chief Pharmacist's Office of the Hospital Authority in Hong Kong. The intervention period will last for 7 days.